Articles tagged with Cancer Patients
A study by University of Minnesota researchers found that elevated levels of APOBEC3B in breast cancer cells lead to reduced response to tamoxifen therapy. Depletion of the protein accelerates development of resistance, while increased production speeds it up.
A new survey tool, COST, measures a patient's risk for financial stress and ability to tolerate it. The study identified employment status, household income, and psychological distress as key factors contributing to financial toxicity.
Studies suggest that population commitment, physician implication, and reassurance in screening can improve participation rates. A patient-centred approach in Australia improved screening participation by offering a combined cancer screening service. Additionally, nurse-led clinics can provide effective early diagnosis and prevention o...
A pooled analysis of NRG Oncology studies RTOG 0129 and 0522 found that IMRT significantly reduced xerostomia and feeding tube dependency in head and neck cancer patients, especially those with oropharyngeal cancer. However, IMRT was associated with increased acute mucositis and dysphagia.
Researchers found that a particular strain of HPV resulted in better overall survival for patients with oropharyngeal cancer. Patients infected with other strains had similar survival rates as those without HPV.
Researchers at Boston University School of Medicine have discovered a new role of the protein c-Cbl in degrading ?-catenin, a vital protein involved in cancer initiation. This finding could lead to new strategies to suppress Colorectal Cancer growth and improve patient survival.
A study published in JAMA Oncology found that training oncologists and their patients to have high-quality discussions improves communication and leads to more clinically meaningful conversations. Despite the focused efforts, shared understanding about prognosis was lacking among patients.
Researchers at Cancer Research UK Cambridge Institute developed an endoscope using near-infrared light to spot early warning signs of oesophageal cancer. The new technique could be used to monitor people with Barrett's oesophagus and prevent some cases of oesophageal cancer.
A randomized clinical trial found that early palliative care significantly increases a patient's ability to cope with their diagnosis and overall quality of life. Patients who received early palliative care were more likely to use adaptive coping strategies and report higher quality of life compared to those receiving standard care alone.
Researchers identified a unique oscillating pattern of a key cancer gene that may contribute to disease progression and treatment resistance. The study found that simultaneous treatment with chemotherapy and targeted drugs can suppress tumor cell growth in both ER+/HER2- and HER2+ subpopulations.
A new survey shows that nearly one-quarter to one-third of family caregivers experience high levels of depression and anxiety symptoms, with self-care behaviors declining as caregiving time increases. Family caregivers can spend over eight hours per day providing care, which affects their mental health if neglected.
A recent study found that many major cancer centers struggle with accessing palliative and supportive care services for patients. Only 37% of callers were told all seven supportive care services were offered, with some staff unsure about availability or unfamiliar with the term.
A recent study analyzing over 1,200 cancer caregivers in the US found that they report a significantly higher burden and spend more hours per week providing care compared to non-cancer caregivers. This highlights the need for better support systems for these individuals.
Researchers have identified three distinct subtypes of esophageal cancer based on genetic signatures, paving the way for tailored treatments. The study suggests patients with specific weaknesses in their DNA repair pathways or immune systems may benefit from targeted therapies, including PARP inhibitors and immunotherapy drugs.
A study suggests that methylnaltrexone can improve the survival of advanced cancer patients with constipation, indicating a potential target for cancer therapy. The drug works by blocking opioid receptors in the gut, reversing constipation without affecting pain relief.
Researchers have discovered a potential new biomarker that can predict cancer patient prognosis and response to treatment. The biomarker is based on the degree of gene overexpression in genes regulating genome integrity.
A large study published in The BMJ found that patients with cancer have a high risk of unintentional and intentional injuries during the diagnostic process. Injuries range from medical complications to accidents and self-harm, affecting specific types of cancer and patient groups differently.
A new study found that cancer screening guidelines for organ transplant recipients are inconsistent, varying in recommendations for skin and other types of cancer. Researchers highlight the need for more studies to inform guidelines involving transplant patients, oncologists, and cancer specialists.
Researchers have identified AMPK as the central enzyme in cancer cachexia, a condition that results in weight loss due to metabolic complications. A peptide was developed to selectively reactivate AMPK, which has been shown to prevent increased fat breakdown and promote 'healthy' adipose tissue.
A nationwide study in England has collected data on 30-day mortality for patients with breast and lung cancer treated with chemotherapy, identifying factors such as age, general well-being, and NHS trusts with higher-than-expected rates of mortality. The study aims to improve patient care and inform clinical decision-making.
Researchers at Houston Methodist developed an AI software that reliably interprets mammograms to predict breast cancer risk. The software achieves 99% accuracy in 30 times human speed, reducing unnecessary biopsies and saving physician hours.
The European Society of Cardiology has launched a position paper to tackle the cardiac toxicity of anticancer therapies. The document reviews nine categories of cardiovascular complications and provides recommendations for detection, prevention, and treatment.
A new study reveals how a cell surface molecule controls T-cell entry into the thymus, offering hope for immunotherapeutic targeting in cancer patients. The research found that stimulating Lymphotoxin beta receptor can enhance initial thymus recovery and boost transplant-derived T-cells.
Researchers at Arizona State University developed a new method to predict which BE patients are at risk of developing cancer. The study highlights the power of studying genetic diversity as a reliable predictor of cancer development and spread.
A new study reveals that socioeconomic differences between white and ethnic minority patients are the main factor affecting their chances of survival. Patients with higher income, insurance status, and marital status tend to have better outcomes.
A new study by Queen Mary University of London found that certain Barrett's Oesophagus cells can be identified as 'born to be benign' or 'bad', allowing for early detection and prevention of oesophageal cancer. The test uses genetic analysis of individual cells, predicting future risk regardless of time since abnormal cell appearance.
A study found that parents are more likely to support laws requiring HPV vaccination for school entry if their state offers opt-out provisions. However, the study's lead author warned that such opt-out provisions may weaken the vaccine requirements' effectiveness.
Patients who initially screened negative for lung cancer but developed the disease one to two years later had more aggressive disease, according to a new study by researchers at Moffitt Cancer Center. The study highlights the importance of continued lung cancer screening in high-risk patients.
A new study suggests that genomic sequencing research may be missing key mutations in different racial and ethnic groups due to a lack of tumor samples from minorities. This could lead to unequal treatment opportunities and worsen disparities in cancer care.
A systematic review found that music interventions significantly reduce cancer patients' anxiety, pain, and fatigue, while improving their quality of life. Music therapy led to a moderate increase in quality of life, while music medicine had less impact.
A new study assesses the effectiveness of self-guided online genetic education in reducing anxiety and stress among cancer patients undergoing tumor gene testing. Researchers hope to improve patients' experience with precision medicine by increasing knowledge about test limitations and benefits.
Researchers at Stanford Medicine developed a machine-learning approach that accurately differentiates between two types of lung cancers and predicts patient survival times better than human pathologists. The method assesses critical disease-related features, including cell size, shape, and texture, to improve patient outcomes.
The new guideline establishes a two millimeter margin as the standard for adequate margins in DCIS treated with whole breast radiation therapy, potentially reducing re-excision rates and improving cosmetic outcomes. This recommendation is supported by evidence and aims to improve quality of care and patient outcomes.
Patients with relapsed or resistant AML experienced responses to venetoclax, a selective BCL-2 inhibitor, with complete remissions in some. The study's results support the mechanism of action of venetoclax and offer potential as a predictive biomarker for BH3 mimetics.
Researchers developed an algorithm called JAMMIT that uses advanced mathematics to identify patterns across multiple molecular data types. The algorithm can accurately predict which patients would benefit most from chemotherapy and combining it with immunotherapy, leading to improved clinical outcomes and reduced costs.
A new study published in Cancer found that uninsured and Medicaid-covered men with testicular cancer had a higher risk of death from the disease compared to insured patients. The researchers analyzed outcomes and insurance status for 10,211 men diagnosed with testicular cancer between 2007 and 2011.
Two new studies found that uninsured or Medicaid-covered cancer patients experience delayed diagnoses, less optimal treatment, and shorter survival times compared to those with other forms of insurance. The research highlights significant disparities in cancer care across different insurance statuses.
A new study has identified gene expression profiles in renal cell carcinoma patients that are less likely to respond to the immunotherapy nivolumab. The study found that tumors with higher levels of metabolism-related genes were more likely to resist treatment and did not benefit from nivolumab, which targets PD-L1 protein.
Researchers found that over half of patients with a rare form of sarcoma had genetic errors in genes known to increase cancer risk, such as p53 and BRCA1. This study provides new clues to the phenomenon of 'cancer families' and suggests that multiple genetic mutations working together may contribute to inherited cancer predisposition.
Researchers have found a way to detect ovarian cancer early using a protein test, providing new hope for patients. An enzyme called SIK2 has been identified as key in making ovarian cancer more deadly, offering a potential new treatment target.
A retrospective clinical study found that patients with melanoma who received both ipilimumab and local peripheral treatments had significantly prolonged overall survival compared to those who received only ipilimumab. The median overall survival for these patients was 93 weeks, compared to 42 weeks for those receiving only ipilimumab.
A new study found delirium to be relatively frequent and underdiagnosed among advanced cancer patients visiting the emergency department, regardless of age. The study highlights the need for better assessment and monitoring of delirium in this population.
A study by Rice University and MD Anderson Cancer Center found significant differences in adherence to recommended cancer treatment for elderly patients across 22 Texas hospital referral regions. Regional variations in treatment rates persist despite the presence of treatment specialists and teaching hospitals.
The review highlights the effectiveness of WHO cancer pain relief guidelines in promoting cancer pain relief. The guidelines have been widely adopted despite initial release in 1986, making them a valuable resource for healthcare providers.
A phase II clinical study found that treating metastatic thyroid cancer patients with the BRAF mutation showed promising anti-tumor activity in a third of patients, with an overall response rate of 38%. The therapy vemurafenib joins other effective treatments for this patient population.
Sorafenib treatment reduces immune-suppressive phenotypes in HCC patients, including decreased PD-1 expression and lower regulatory T cells. These responses correlate with increased overall survival.
A new study found that while more imaging after thyroid cancer treatment identifies recurrence, it does not always lead to improved survival. Radioiodine scans, however, were associated with better outcomes.
A high dietary intake of omega 3 fatty acids from oily fish may help lower the risk of death from bowel cancer in patients diagnosed with the disease. Patients with a higher omega 3 intake were found to have a 41% lower risk of dying from their disease, according to researchers.
Cancer Research UK has tripled its investment in pancreatic cancer research, aiming to improve diagnosis and treatment. The charity hopes to develop better treatments and improve survival rates for patients affected by the disease.
Researchers discovered a correlation between rare POLE mutations in bowel cancers and improved patient outcomes. These tumours are less likely to recur, particularly when diagnosed at an early stage.
Researchers found daily meetings between physicians and intensivists, care protocols, and pharmacist presence are associated with increased survival rates among cancer patients in ICUs. These simple processes can reduce mortality by up to 70% and promote cost reduction.
A study at the University of Texas MD Anderson Cancer Center found that genetic mutations in DNA mismatch repair deficiency (dMMR) are present in 15% of colorectal cancer cases. The study identified MSH2 and MSH6 as the most commonly affected genes, providing a new approach to diagnosis and treatment using precision medicine.
The GW Cancer Center will train patients and healthcare providers on how to improve communications for better health, with a focus on patient health literacy and cultural sensitivity. The project aims to examine the impact of various factors such as gender, race, and income on the patient-provider relationship.
Researchers have found an association between adjuvant chemotherapy and improved survival in stage 2 colon cancer patients, contradicting current clinical guidelines. The study analyzed 153,110 patients with stage 2 colon cancer and found that those who received adjuvant chemotherapy survived longer than those who did not.
The Damon Runyon Cancer Research Foundation has awarded over $4 million to 10 top clinical investigators to support patient-oriented cancer research. The award aims to address the shortage of physicians capable of translating scientific discovery into new breakthroughs for cancer patients.
A study found that nearly all cancer patients overestimate their chances of survival compared to their doctors' estimates. The researchers emphasize the importance of accurate communication between physicians and patients in making informed treatment decisions.
A new study finds that most patients with advanced cancer report optimistic survival expectations despite clinicians' more conservative estimates. Patients from diverse backgrounds also show disparities in understanding their oncologists' opinions.
A national initiative prioritized research on venous thrombosis (VTE) in cancer patients, citing a 20% prevalence rate and increased risk with chemotherapy. The study identified key areas for future research, including platelet contributions to VTE and the impact of cancer therapies on blood cells.
A new study found that patients who develop heart failure after their first heart attack are at a higher risk of developing cancer. After an average of 4.9 years of follow-up, 21% of these patients were diagnosed with cancer, compared to 8.2% of those without heart failure.
The Moffitt Cancer Center is conducting a nationwide study on e-cigarette use, tracking 2,500 adult smokers who use both cigarettes and e-cigarettes. The study aims to understand the long-term impact of e-cigarettes on traditional cigarette use.